Factors Influencing the Expenditure on the Treatment of Oncological Disorders in the Czech Republic


  • Ing. Pavel Havlík Vysoká škola ekonomická v Praze, fakulta financí a účetnictví, katedra veřejných financ




expenditure on neoplasms, exchange rate, deaths from cancer, technological progress, cancer illnesses costly


The article deals with the current issues in contemporary healthcare. Health care spending is constantly rising. Sectors that take care of the treatment of patients with some type of cancer are especially financially demanding. The main goal of the article is to quantify the impact of selected factors on expenditure on cancer treatment. The article examines three factors in particular – the exchange rate, technological progress and the death of cancer patients. It works with several time series, which include data from the years 2000–2017. Expenditures on the treatment of cancer patients to the total expenditures on health care in the Czech Republic are significantly affected by the exchange rate. Technological progress is also of great importance in the growth of expenditures in the treatment of oncology patients. Newer and more modern devices and medicines are more efficient, save more lives, prolong human life, but are more expensive, and therefore further growth in spending must be expected. Deaths from cancer are also affected by the cost of treating cancer, as saving every human life increases the cost of treating it.


ARLT, J., ARLTOVÁ, M., Ekonomické časové řady. 1.vyd. Praha: Professional Publishing, 2009, s. 290. ISBN: 978-80-86946-85-6

BERGEAUD, A., CETTE, G., LECAT, R., (2013). Long-Term productivity database [online]. [cit. 2020-09-25] Dostupné z: http://www.longtermproductivity.com

BIEMAR, F., FOTI, M., (2013). Global progress against cancer—challenges and opportunities [online]. [cit.2021-01-11] Dostupné z: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860343/

CARRERA, P.M., KANTARJIAN, H.M., BLINDER, V.S., (2018). The Financial Burden and Distress of Patients with Cancer: Understanding and Stepping-Up Action on the Financial Toxicity of Cancer Treatment [online]. [cit.2020-11-05] Dostupné z: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652174/

ČESKÝ STATISTICKÝ ÚŘAD. Dostupné z: https://www.czso.cz

DURČÁKOVÁ, J., MANDEL M., Mezinárodní finance. 4. vydání Praha: Management press, (2010), s. 493. ISBN 978-80-7261-221-5

FERRETTI, F., JONES, S., MCINTOSH, B. (2013). Long-Run Macroeconomic Determinants of Cancer Incidence [online]. [cit.2020-10-08] Dostupné z: http: https://bradscholars.brad.ac.uk/bitstream/handle/10454/6623/IJSMR%20Long-Run%20Macroeconomic%20Determinants%20of%20Cancer%20Incidence.pdf?sequence=1&isAllowed=y

GORDON, L.G., WALKER, S.L., MERVIN, M.C., LOWE. A., SMITH. D.P., GARDINER. R.A., CHAMBERS. S.K., (2017). Financial toxicity: a potential side effect of prostate cancer treatment among Australian men [online]. [cit.2021-11-05] Dostupné z: https://pubmed.ncbi.nlm.nih.gov/26423576/

HAN, X., LIN, CH., LI, CH., DE MOOR, J.S., RODRIGUEZ, J. L., KENT, E.E., FORSYTHE, L.P., (2014). Association between serious psychological distress and health care use and expenditures by cancer history [online]. [cit.2020-10-05] Dostupné z: https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.29102

JEFFERYS, D.B., (2001). The regulation of medici devices and the role of the Medical Devices Agency [online]. [cit.2020-11-05] Dostupné z: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014554/

LEIGH, D., LIAN, W., POPLAWSKI-RIBEIRO, M., SZYMANSKI, R., TSYRENNIKOV, V., YANG, H., (2017). Exchange Rates and Trade: A Disconnect? [online]. [cit.2021-01-10] Dostupné z: https://www.imf.org/en/Publications/WP/Issues/2017/03/15/Exchange-Rates-and-Trade-A-Disconnect-44746


NÁKLADY NA LÉČBU PACIENTŮ S RAKOVINOU ROSTLY ZA PĚT LET O 20 PROCENT. [online]. [cit.2020-10-08] Dostupné z: https://www.zdravotnickydenik.cz/2018/02/naklady-lecbu-pacientu-rakovinou-rostly-za-pet-let-20-procent/

NA LÉČBU RAKOVINY VYDÁ ZP 211 ROČNĚ PŘES DVĚ MILIARDY [online]. [cit. 2020-11-30] Dostupné z: https://www.zpmvcr.cz/o-nas/aktuality/na-leceni-rakoviny-vyda-zp-211-rocne-pres-dve-miliardy/

NOVOTVARY 2016 ČR (2016). [online]. [cit.2020-10-16] Dostupné z: https://www.uzis.cz › system › files › novotvary2016

SMITH, S., (2014). Cancer Treatment: The Cost Factor [online]. [cit.2021-01-02] Dostupné z: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668973/


WORLD HEALTH ORGANIZATION (2018). TECHNICAL REPORT Pricing of cancer medicines and its impacts [online]. [cit.2021-01-03] Dostupné z: https://apps.who.int/iris/bitstream/handle/10665/277190/9789241515115-eng.pdf?ua=1

YABROFF, K. R., LUND, J., KEPKA, D., MARIOTTO, A., (2012). Economic Burden of Cancer in the US: Estimates, Projections, and Future Research [online]. [cit.2021-01-03] Dostupné z: https://apps.who.int/iris/bitstream/handle/10665/277190/9789241515115-eng.pdf?ua=



How to Cite

Havlík, P. (2021). Factors Influencing the Expenditure on the Treatment of Oncological Disorders in the Czech Republic. Socio-Economic and Humanities Studies, 14(2), 41–55. https://doi.org/10.61357/sehs.v14i2.31